Getting your Trinity Audio player ready...

Special to the Advance

Breast cancer is the second most common cancer in women in the United States, with more than 250,000 diagnoses each year.

Atmore Community Hospital (ACH) announced recently that it’s offering two of the latest breast cancer technologies, Senographe Pristina 3D mammography system and SenoBright and technologies by GE Healthcare, providing more options to patients and their providers, improving the patient experience, and enhancing clinical outcomes, according to a release.

While screening mammograms are a critical step in catching breast cancer early, clinical tools like MRI and ultrasound have traditionally been used to do any additional diagnostic exams. SenoBright technology uses a novel technique to quickly highlight any areas of concern and allow providers to examine further.

“The women in our community hold a special place in our lives and we want to do everything in our power to take care of them. Whether it is a routine screening or diagnostic mammogram, being able to offer a comfortable and personalized experience with state-of-the-art technology is important to early detection and improving outcomes,” said Brad Lowery, ACH administrator. “We’re excited to offer 3D mammography at Atmore Community Hospital as a tool to make meaningful positive impacts for the women in our community.”

SenoBright works in tandem with the Senographe Pristina mammography system at Atmore Community Hospital, which radiologists use to image the breast. The technology first uses a contrast medium to highlight the area of concern. During this approach, called contrast-enhanced spectral

mammography (CESM), doctors inject contrast through an IV so that X-rays can illuminate vascularity in the breast and show clinicians where a potential tumor might lie.

ACH is the only facility in the Atmore area using CESM. Talk to your primary care physician to see if you are due for your screening mammograms today.